DeepHealth vs Gleamer
RadNet announced the Gleamer purchase on March 2, 2026 at up to EUR 230M, and gleamer.ai now reads "Gleamer is now part of DeepHealth". The product is still sold under the Gleamer name, and RadNet's release says AI deployment inside RadNet comes by the third quarter of 2026. The FDA applicant records stay separate. Gleamer's list holds BoneView (March 2022, March 2023), BoneMetrics and ChestView US, the newest being version 1.1 in September 2026. DeepHealth's ten records name Saige-Dx, Saige-Density, Saige-Q, BAC software and TechLive.
Gleamer's US clearances are mostly X-ray, and an emergency radiology service reading fractures and chest films is its buyer. DeepHealth's line starts with breast, adds prostate, lung, brain and thyroid under Population Health, and breast screening programs are its buyer. A fracture reading room and a mammography program buy different products from the same owner.
Radiology · Reviewed November 2, 2026
DeepHealth
by RadNet / DeepHealth, Inc.
Imaging AI from RadNet's DeepHealth: mammography (Saige-Dx, Saige-Density), breast arterial calcification, prostate, lung, bone and chest X-ray.
Gleamer
by Gleamer SAS
Radiology AI for fracture and chest X-ray findings, plus CT, MRI and mammography; part of RadNet DeepHealth since March 2026.
When to pick each one
DeepHealth
- Saige-Dx mammography, K253825 decided June 2026
- BAC software cleared May 2026
- Prostate, lung and brain AI beyond breast
Gleamer
- BoneView cleared twice, March 2022 and March 2023
- ChestView US 1.1 decided September 2026
- Reporting AI with Voice and AutoReport
Score
Each row shows points earned of points available under the published rubric.
DeepHealth
48of 100
Gleamer
56of 100
| Dimension | DeepHealth | Gleamer | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 7.3 / 18.2 | 18.2 / 18.2 | -10.9 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 0 / 7.8 | 0 |
| Funding & adoption signal | 12 / 12 | 8.4 / 12 | +3.6 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
DeepHealth
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The homepage shows none. |
Gleamer
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Demo request only. |
Evidence
DeepHealth
FDA decisions
K252486 (opens in new tab)510(k)2026-09-09
ChestView US 1.1 (Gleamer)
K253825 (opens in new tab)510(k)2026-06-15
Saige-Dx
K254131 (opens in new tab)510(k)2026-05-21
Breast arterial calcification (BAC) software
K251873 (opens in new tab)510(k)2025-08-11
Saige-Dx
K243703 (opens in new tab)510(k)2025-06-05
TechLive
Show 13 more
K241620 (opens in new tab)510(k)2025-02-27
ChestView US (Gleamer)
K241593 (opens in new tab)510(k)2025-02-05
BoneMetrics (Gleamer)
K243688 (opens in new tab)510(k)2024-12-19
Saige-Dx 3.1.0
K243705 (opens in new tab)510(k)2024-12-19
Saige-Density 2.5.0
K241747 (opens in new tab)510(k)2024-11-18
Saige-Dx
K240417 (opens in new tab)510(k)2024-11-08
ProFound Detection V4.0 (iCAD)
K222176 (opens in new tab)510(k)2023-03-02
BoneView (Gleamer)
K222275 (opens in new tab)510(k)2022-12-16
Saige-Density
K220105 (opens in new tab)510(k)2022-05-12
Saige-Dx
K212365 (opens in new tab)510(k)2022-03-01
BoneView (Gleamer)
K203517 (opens in new tab)510(k)2021-04-16
Saige-Q (triage)
K203822 (opens in new tab)510(k)2021-03-12
ProFound AI V3.0 (iCAD)
K191994 (opens in new tab)510(k)2019-10-04
ProFound AI V2.1 (iCAD)
Peer-reviewed
1 PubMed record names DeepHealth.
Gleamer
FDA decisions
K252486 (opens in new tab)510(k)2026-09-09
ChestView US (1.1)
K241620 (opens in new tab)510(k)2025-02-27
ChestView US
K241593 (opens in new tab)510(k)2025-02-05
BoneMetrics (US)
K213253 (opens in new tab)510(k)2023-06-30
Pixyl.Neuro
K222176 (opens in new tab)510(k)2023-03-02
BoneView
Show 1 more
K212365 (opens in new tab)510(k)2022-03-01
BoneView
Peer-reviewed
5 PubMed records name Gleamer.
- Opinion paper: artificial intelligence as a clinical ally in lung cancer detection-the case for Gleamer's ChestView. (opens in new tab)
- AI model for automatic spinopelvic and spinal alignment parameters measurement from EOS. (opens in new tab)
- Fracture Detection on Bone Radiographs: The Impact of an AI Tool on Orthopaedic Night Shifts. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | DeepHealth | Gleamer |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | US | FR |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.